Lamisil Uno

Terbinafine, the active ingredient in Lamisil Uno, is a allylamine antifungal presented as a topical formulation for skin use. It is employed to treat superficial fungal infections of the skin, particularly in the feet, body and groin areas.

GNH USA supplies Lamisil Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil Uno, an allylamine antifungal, is indicated for common dermatophyte infections of the skin.

- Tinea pedis: reduces fungal growth and relieves itching and scaling on the feet. - Tinea corporis: clears ring‑shaped lesions on the body by eradicating the causative fungus. - Tinea cruris: treats fungal infection of the groin area, improving redness and discomfort.

Lamisil Uno may cause local skin reactions and, rarely, systemic effects.

Common Side Effects: - Burning sensation: mild to moderate discomfort at the application site. - Itching: transient pruritus after use. - Redness: localized erythema. - Dryness: skin may become flaky. - Peeling: superficial desquamation. - Stinging: brief sharp sensation.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Contact dermatitis: intense rash or blistering. - Systemic toxicity: rare liver enzyme elevation. - Hyperpigmentation: persistent darkening of the skin. - Secondary infection: bacterial infection of the treated area. - Persistent ulceration: non‑healing skin breakdown.

Before using Lamisil Uno, consider the following safety measures.

- Avoid application on broken skin: do not apply to open wounds or irritated areas. - Test for sensitivity: perform a small patch test if a history of skin reactions exists. - Limit use to indicated infections: do not use for viral or bacterial skin conditions. - Discontinue if severe irritation occurs: stop treatment and seek medical advice. - Keep away from eyes and mucous membranes: avoid contact with eyes, nose, and mouth. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Terbinafine topical has limited systemic interaction potential, but caution is advised with certain co‑administered agents.

Major Interactions (Avoid): - Concurrent systemic terbinafine: may increase overall exposure and risk of systemic toxicity. - Other topical antifungals containing azoles: can cause additive irritation.

Moderate Interactions (Monitor Closely): - Alcohol-based skin products: may enhance skin irritation. - Topical corticosteroids: may mask signs of infection progression. - Occlusive dressings: increase drug absorption and potential irritation. - Sunscreen or cosmetic creams applied over the area: may alter drug efficacy. - Herbal skin preparations: unknown interaction, monitor for adverse reactions.